Latest Biotech Startup Funding Rounds

Financing for drug discovery, therapeutics and biological technologies, with the development context behind each round.

This page showsSector: Biotech
Rounds
603
All time
Disclosed funding
$28.7B
480 disclosed amounts
Median round
$17M
Of disclosed amounts
603 rounds
Funding rounds
CompanyAmountRoundSectorCountryInvestorsAnnounced
AbbelightBiotech · FranceCompany profile

Microscopy and nanoscopy systems combining chemistry, optics and analysis for life-science researchers.

Microscopy and nanoscopy systems combining chemistry, optics and analysis for life-science researchers.

UndisclosedSeries BBiotechFranceInvestors
Enodia TherapeuticsBiotech · FranceCompany profile

Develops small-molecule therapies for targeted protein degradation at the point of synthesis

Develops small-molecule therapies for targeted protein degradation at the point of synthesis

€20.7MSeedBiotechFranceInvestors
EpiBiologicsBiotech · United StatesCompany profile

Develops bispecific antibodies for targeted degradation of extracellular proteins.

Develops bispecific antibodies for targeted degradation of extracellular proteins.

$107MSeries BBiotechUnited StatesInvestors
Perceptive DiscoveryBiotech · United KingdomCompany profile

Provides preclinical and translational solutions for oncology and radiopharmaceutical programs

Provides preclinical and translational solutions for oncology and radiopharmaceutical programs

$15MStrategicUndisclosedBiotechUnited KingdomInvestors
Parabilis MedicinesBiotech · United StatesCompany profile

Develops medicines targeting historically undruggable protein targets in cancer

Develops medicines targeting historically undruggable protein targets in cancer

$305MSeries FSeries C+BiotechUnited StatesInvestors
Nocion TherapeuticsBiotech · United StatesCompany profile

Nocion Therapeutics develops small-molecule therapies for conditions involving cough and itch.

Nocion Therapeutics develops small-molecule therapies for conditions involving cough and itch.

$23MSeries B+Series BBiotechUnited StatesInvestors
Undisclosed
STRM.BIOBiotech · United StatesCompany profile

Develops non-viral gene delivery platform for in vivo cell engineering and gene therapy

Develops non-viral gene delivery platform for in vivo cell engineering and gene therapy

$8MSeed2SeedBiotechUnited StatesInvestors
Poplar TherapeuticsHealthtech · United StatesCompany profile

Developing a new class of anti-IgE therapy to treat food allergy and other atopic conditions

Developing a new class of anti-IgE therapy to treat food allergy and other atopic conditions

$50MSeries ABiotech, HealthtechUnited StatesInvestors
Mediar TherapeuticsBiotech · United StatesCompany profile

Develops therapies to halt fibrosis in multiple organ systems

Develops therapies to halt fibrosis in multiple organ systems

$76MSeries BBiotechUnited StatesInvestors
Prudentia SciencesBiotech · United StatesCompany profile

Provides AI-native due diligence for life sciences dealmaking

Provides AI-native due diligence for life sciences dealmaking

$20MSeries ABiotechUnited StatesInvestors

Active investors in this selection

All investors →

Ranked by rounds participated in · All time

  1. 1
    RA Capital Management

    Delix Therapeutics, Alethio Therapeutics, Estuary Biotherapeutics

    27rounds
    6led
  2. 2
    Eli Lilly and Company

    Oyster Therapeutics, BigHat Biosciences, Circle Pharma, Inc.

    16rounds
    0led
  3. 3
    Janus Henderson Investors

    Star Therapeutics, OMass Therapeutics, Soufflé Therapeutics

    16rounds
    1led
  4. 4
    ARCH Venture Partners

    Soufflé Therapeutics, Encoded Therapeutics Inc., Moonwalk Biosciences

    16rounds
    1led
  5. 5
    OrbiMed

    Dren Bio, Star Therapeutics, Leal Therapeutics

    12rounds
    1led

Latest digests

Archive →

Explore published rounds while the next edition is being prepared.

Browse rounds by topic